GeneDx Holdings
240 hedge funds and large institutions have $2.01B invested in GeneDx Holdings in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 100 increasing their positions, 71 reducing their positions, and 83 closing their positions.
128% more call options, than puts
Call options by funds: $34.2M | Put options by funds: $15M
41% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 71
0.51% less ownership
Funds ownership: 107.22% → 106.7% (-0.51%)
16% less funds holding
Funds holding: 286 → 240 (-46)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
48% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 83
50% less capital invested
Capital invested by funds: $4.03B → $2.01B (-$2.02B)
Top Buyers
Top Sellers
WGS Hedge Fund Activity: Q1 2026 in Review
240 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2026, worth a combined $2.01B — down 50% from $4.03B a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of WGS and 43 opened new positions — a net loss of 40 holders — while 71 trimmed existing stakes and 100 added.
The largest buyer was ARK Investment Management, adding an estimated $65.7M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $51.4M sold.
- 240 institutional investors held GeneDx Holdings (WGS) as of Q1 2026, down from 286 in Q4 2025.
- Funds reported $2.01B of GeneDx Holdings stock for Q1 2026, down 50% quarter-over-quarter.
- 43 funds opened new GeneDx Holdings positions in Q1 2026 and 83 closed out, a net change of -40 holders.
- The largest GeneDx Holdings buyer in Q1 2026 was ARK Investment Management, an estimated $65.7M added.
- The largest GeneDx Holdings seller in Q1 2026 was Driehaus Capital Management, an estimated $51.4M sold.
Based on aggregated 13F filings for Q1 2026.